|
[1]Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
|
[2]ANDREANI T,SERFATY L,MOHAND D,et al.Chronic hepatitis B virus carriers in the immunotolerant phase of infection:histologic findings and outcome[J].Clin Gastroenterol Hepatol,2007,5(5):636-641.
|
|
[3]HUI CK,LEUNG N,YUEN ST,et al.Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase[J].Hepatology,2007,46(2):395-401.
|
|
[4]TSENG TC,KAO JH.Treating Immune-tolerant Hepatitis B[J].J Viral Hepat,2015,22(2):77-84.
|
|
[5]LAI M,HYATT BJ,NASSER I,et al.The clinical significance of persistently normal ALT in chronic hepatitis B infection[J].J Hepatol,2007,47(6):760-767.
|
|
[6]KUMAR M,SARIN SK,HISSAR S,et al.Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT[J].Gastroenterology,2008,134(5):1376-1384.
|
|
[7]DEGERTEKIN B,LOK A.Should liver biopsies be performed on all hepatitis B carriers?[J].Gastroenterology,2008,135(5):1802.
|
|
[8]CHEN YC,CHU CM,LIAW YF.Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B[J].Hepatology,2010,51(2):435-444.
|
|
[9]WONG GL,WONG VW,CHOI PC,et al.Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients[J].Clin Gastroenterol Hepatol,2009,7(2):227-233.
|
|
[10]PAPATHEODORIDIS GV.Hepatitis B virus treatment:which patients can have treatment deferred?[J].Clin Liver Dis,2013,2(1):15-17.
|
|
[11]KIM HC,NAM CM,JEE SH,et al.Normal serum aminotransferase concentration and risk of mortality from liver diseases:prospective cohort study[J].BMJ,2004,328(7446):980-983.
|
|
[12]PRATI D,TAIOLI E,ZANELLA A,et al.Updated definitions of healthy ranges for serum alanine aminotransferase levels[J].Ann Intern Med,2002,137(1):1-10.
|
|
[13]KAO JH,CHEN DS.Critical analysis of the immune tolerance phase of chronic HBV infection:natural history and diagnosis[J].Curr Hepat Rep,2008,7(1):5-11.
|
|
[14]SARIN SK,KUMAR M,LAU GK,et al.Asian-Pacific clinical practice guidelines on the management of hepatitis B:a 2015 update[J].Hepatology International,2016,10(1):1-98.
|
|
[15]CHU CM,LIAW YF.Chronic hepatitis B virus infection acquired in childhood:special emphasis on prognostic and therapeutic implication of delayed HBe Ag seroconversion[J].J Viral Hepat,2007,14(3):147-152.
|
|
[16]de FRANCHIS R,MEUCCI G,VECCHI M,et al.The natural history of asymptomatic hepatitis B surface antigen carriers[J].Ann Intern Med,1993,118(3):191-194.
|
|
[17]MANNO M,CAMMA C,SCHEPIS F,et al.Natural history of chronic HBV carriers in northern Italy:morbidity and mortality after30 years[J].Gastroenterology,2004,127(3):756-763.
|
|
[18]MARTINOT-PEIGNOUX M,BOYER N,COLOMBAT M,et al.Serum hepatitis B virus DNA levels and liver histology in inactive HBs Ag carriers[J].J Hepatol,2002,36(4):543-548.
|
|
[19]VILLENEUVE JP,DESROCHERS M,INFANTE-RIVARD C,et al.A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal[J].Gastroenterology,1994,106(4):1000-1005.
|
|
[20]HSU YS,CHIEN RN,YEH CT,et al.Long-term outcome after spontaneous HBe Ag seroconversion in patients with chronic hepatitis B[J].Hepatology,2002,35(6):1522-1527.
|
|
[21]FATTOVICH G,OLIVARI N,PASINO M,et al.Long-term outcome of chronic hepatitis B in Caucasian patients:mortality after 25years[J].Gut,2008,57(1):84-90.
|
|
[22]HABERSETZER F,MOENNE-LOCCOZ R,MEYER N,et al.Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection[J].Liver Int,2015,35(1):130-139.
|
|
[23]MARTINOT-PEIGNOUX M,LADA O,CARDOSO ACF,et al.Quantitative HBs Ag:a new specific marker for the diagnosis of HBs Ag inactive carriage[J].Hepatology,2010,52(4):992a.
|
|
[24]BRUNETTO MR,OLIVERI F,COLOMBATTO P,et al.Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers[J].Gastroenterology,2010,139(2):483-490.
|
|
[25]HADZIYANNIS SJ,VASSILOPOULOS D.Hepatitis B e Antigen negative chronic hepatitis B[J].Hepatology,2001,34(4 Pt 1):617-624.
|
|
[26]FUNK ML,ROSENBERG DM,LOK AS.World-wide epidemiology of HBe Ag-negative chronic hepatitis B and associated precore and core promoter variants[J].J Viral Hepat,2002,9(1):52-61.
|
|
[27]HADZIYANNIS SJ.Milestones and perspectives in viral hepatitis B[J].Liver Int,2011,31(Suppl 1):129-134.
|
|
[28]CHU CM,LIAW YF.Spontaneous relapse of hepatitis in inactive HBs Ag carriers[J].Hepatol Int,2007,1(2):311-315.
|
|
[29]CROAGH CM,LUBEL JS.Natural history of chronic hepatitis B:phases in a complex relationship[J].World J Gastroenterol,2014,20(30):10395-10404.
|
|
[30]HUANG R,JIANG N,YANG R,et al.Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B[J].Exp Ther Med,2016,11(5):1673-1677.
|
|
[31]WONG GL,CHAN HL,WONG CK,et al.Liver stiffnessbased optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B[J].J Hepatol,2014,60(2):339-345.
|
|
[32]INVERNIZZI F,VIGANM,GROSSI G,et al.The prognosis and management of inactive HBV carriers[J].Liver International,2016,36(Suppl 1):100-104.
|
DownLoad: